The invention discloses a cholelithiasis treatment
drug, and belongs to the technical field of traditional Chinese medicines. The cholelithiasis treatment
drug is prepared from three groups of bulk drugs, wherein the first group of the drugs comprises japanese climbing
fern spore, cape jasmine, submature bitter orange, common burreed tuber, blue turmeric
rhizome, rheum, christina loosestrife
herb, amur corktree
bark, Chinese thorowax root,
salvia miltiorrhiza and chicken's
gizzard-membrane, the second group of the drugs comprises Chinese thorowax root, christina loosestrife
herb, amur corktree
bark, white peony root, chicken's
gizzard-membrane,
silybum marianum, costusroot,
corydalis tuber,
salvia miltiorrhiza, tuckahoe, asiatic plantain seed, wenchow turmeric root tuber, Japanese climbing
fern spore, submature bitter orange and cape jasmine, the third group of the drugs comprises Chinese thorowax root,
salvia miltiorrhiza, finger citron fruit, noble
dendrobium stem
herb, baikal skullcap root, dangshen, tuckahoe,
areca peel,
common jujube, largehead atractylodes
rhizome,
milkvetch root, common yam
rhizome, immature
tangerine fruit, angelica, villous amonmum fruit, hawthorn and licorice root, the first group of the
drug is continuously taken 10-20 days, the second group of the drug is continuously taken 10-20 days, and the third group of the drug is continuously taken 5-8 days. According to the present invention, cholelithiasis treatment is divided into three stages, an effective rate is 100%, and recurrence is not easily generated after
disease treatment.